<DOC>
	<DOCNO>NCT00598637</DOCNO>
	<brief_summary>The purpose study evaluate efficacy two different drug-eluting stent ( Everolimus Zotarolimus-eluting ) treatment unprotected leave main coronary artery disease .</brief_summary>
	<brief_title>Drug-eluting Stents Treat Unprotected Coronary Left Main Disease</brief_title>
	<detailed_description>Restenosis leave main coronary artery may severe consequence give large proportion myocardium compromise condition , , several study , link 6-month mortality index procedure . Drug-eluting stent reduce restenosis rate need target vessel revascularization simple lesion also high risk subset patient lesion diabetic , long lesion bifurcation . There data efficacy leave main coronary artery disease . Thus , aim study investigate performance two different drug-eluting stent ( Everolimus Zotarolimus-eluting ) leave main coronary lesion .</detailed_description>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Patients old age 18 ischemic symptom evidence myocardial ischemia presence ≥ 50 % stenosis locate unprotected LMCA unable undergo CABG cardiac surgeon ' refusal ( poor surgical candidate ) unwillingness . Pretreatment load dose 600 mg clopidogrel . Informed , write consent patient her/his legallyauthorized representative participation study . Cardiogenic shock . STsegment elevation acute myocardial infarction ( STsegment ≥ 0.1 mV elevation ≥ 2 contiguous ECG lead persist least 20 minute ) within 48 hour symptom onset . Instent restenosis . Malignancies comorbid condition life expectancy le one year may result protocol noncompliance . Prior coronary artery bypass surgery revascularization LAD and/or LCx . Planned stag PCI procedure within 30 day index procedure prior PCI within last 30 day . An elective surgical procedure plan would necessitate interruption clopidogrel first six month post enrollment . Known allergy study medication : aspirin , clopidogrel , UHF ; sirolimus , paclitaxel ; true anaphylaxis prior exposure contrast medium . Pregnancy ( present , suspected plan ) . Patient 's inability fully cooperate study protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>drug elute stent</keyword>
	<keyword>leave main disease</keyword>
</DOC>